Skip to main content

Currently Skimming:


Pages 71-79

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 71...
... PART IV Methoclological Issues and Work in Progress
From page 73...
... He discusses the uses and limitations of claims data for out comes research.
From page 74...
... Usually, it refers to administrative records, or insurance claims data, regarding patients receiving various treatments. The nice thing about using claims for research purposes is that someone else actually collects the data, namely, providers filling out the claims forms.
From page 75...
... USES OF LARGE DATA BASES Probably the most common use of claims data for effectiveness research is to follow patients with a specific diagnosis or patients receiving a specific therapy. Diagnoses are available on institutional claims; procedures are documented on all physician bills.
From page 76...
... Using claims data to examine outcomes associated with ambulatory episodes of care is more problematic because of the absence of diagnostic information on the Part B claims. Thus it is not possible to determine the reason for a given office visit or to trace referral patterns accurately.
From page 77...
... The researcher cannot tell this from the claims data, however, and it will appear as if twice the number of pacemakers were inserted in that area. One carrier has dealt with the team approach by having one physician bill for the insertion, while the other physician bills for pacemaker repair.
From page 78...
... Because state Medicaid programs do cover these services, however, Medicaid claims can be used to fill some important gaps. Similarly, because Medicaid pays for most prescription drugs, these claims can be used to evaluate alternative treatments or to identify a sample of patients undergoing a given treatment regimen: for example, all AIDS patients receiving AZT.
From page 79...
... Repeal of the Act in late 1989 deprived researchers of the opportunity to broaden the questions that could be addressed using Medicare claims data and thus expand effectiveness and outcomes research.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.